To Evaluate the Efficacy and Safety of Mifepristone in Reducing the Size & Symptoms of Uterine Leiomyoma/Fibroids.

Suruchi DesaiShreya OswalChirag PatelRashmi Parikh

Published in: Journal of obstetrics and gynaecology of India (2024)

This prospective study highlights mifepristone's promise as a non-surgical approach to effectively reduce uterine fibroid volume, improve hemoglobin levels, and mitigate uterine blood loss in patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
pregnant women
big data
patient reported outcomes
depressive symptoms
physical activity